The aim of this study was to explore the association of body mass index (BMI), waist circumference (WC), and BMI and WC changes over time with cognitive decline in a nationally representative sample.
Methods:
A total of 5239 participants (≥65 years) were followed for 3 years as part of the National Health and Aging Trends Study. Cox proportional hazard regression was applied to model the risk of cognitive decline.
Results:
BMI, after adjusting for WC and main confounders, was associated with reduced risk of cognitive decline (hazard ratio [HR] 0.97 for each unit BMI increase, 0.95-0.99). After stratifying by gender and age, this effect remained significant among females and young elders ≤80 years. A BMI decrease and WC increase >10% over the study period were associated with increased risk of cognitive decline (HR 1.98, 1.16-3.38; HR 1.30, 1.04-1.62, respectively).
Conclusion:
In the elderly individuals, lean mass, as measured by BMI adjusted for WC, was associated with reduced risk of cognitive decline. Loss of lean mass and gain of fat mass, as measured by WC adjusted for BMI, were associated with elevated risk of cognitive decline.
FinkelsteinEAKhavjouOAThompsonH. Obesity and severe obesity forecasts through 2030. Am J Prev Med. 2012;42(6):563–570.
4.
EmmerzaalTLKiliaanAJGustafsonDR. 2003-2013: a decade of body mass index, Alzheimer’s disease, and dementia. J Alzheimers Dis. 2015;43(3):739–755.
5.
BeydounMBeydounHWangY. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev. 2008;9(3):204–218.
6.
Guallar-CastillónPBalboa-CastilloTLópez-GarcíaE. BMI, waist circumference, and mortality according to health status in the older adult population of Spain. Obesity. 2009;17(12):2232–2238.
7.
KasperJFreedmanV. National Health and Aging Trends Study (NHATS) User Guide: Rounds 1, 2& 3 Final Release. Baltimore, MD: Johns Hopkins University School of Public Health; 2015.
8.
GalvinJRoeCPowlishtaK. The AD8 A brief informant interview to detect dementia. Neurology. 2005;65(4):559–564.
9.
CrimminsEMKimJKLangaKMWeirDR. Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study. J Gerontol B Psychol Sci Soc Sci. 2011;66(suppl 1):162–171.
10.
ShulmanKI. Clock-drawing: is it the ideal cognitive screening test?Int J Geriatr Psychiatry. 2000;15(6):548–561.
11.
KasperJDFreedmanVASpillmanBC. Classification of persons by dementia status in the National Health and Aging Trends Study. 2013. www.nhats.org. Accessed May 20, 2016.
12.
Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res. 2002;10(suppl 12):97S–104S.
13.
AttiARPalmerKVolpatoSWinbladBDe RonchiDFratiglioniL. Late-Life Body Mass Index and Dementia Incidence: Nine-Year Follow-Up Data from the Kungsholmen Project. J Am Geriatr Soc. 2008;56(1):111–116.
14.
NourhashemiFDeschampsVLarrieuS. Body mass index and incidence of dementia: the PAQUID study. Neurology. 2003;60(1):117–119.
15.
HughesTBorensteinASchofieldEWuYLarsonEB. Association between late-life body mass index and dementia The Kame Project. Neurology. 2009;72(20):1741–1746.
16.
GorberSCTremblayMMoherDGorberB. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev. 2007;8(4):307–326.
17.
SpencerEAApplebyPNDaveyGKKeyTJ. Validity of self-reported height and weight in 4808 EPIC–Oxford participants. Public Health Nutr. 2002;5(04):561–565.
18.
JanssenIKatzmarzykPTRossR. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79(3):379–384.
19.
HeiatAVaccarinoVKrumholzHM. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med. 2001;161(9):1194–1203.
20.
KasperJFreedmanVNiefeldM. Construction of Performance-Based Summary Measures of Physical Capacity in the National Health and Aging Trends Study. Baltimore, MD: Johns Hopkins University School of Public Health; 2012.
21.
WildBEcklAHerzogW. Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study. Am J Geriatr Psychiatry. 2014;22(10):1029–1038.
22.
BoyleLLRichardsonTMHeH. How do the phq-2, the phq-9 perform in aging services clients with cognitive impairment?Int J Geriatr Psychiatry. 2011;26(9):952–960.
23.
BeeriMSDavidsonMSilvermanJM. Relationship between body height and dementia. Am J Geriatr Psychiatry. 2005;13(2):116–123.
24.
MichelsKBGreenlandSRosnerBA. Does body mass index adequately capture the relation of body composition and body size to health outcomes?Am J Epidemiol. 1998;147(2):167–172.
25.
FitzpatrickALKullerLHLopezOL. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66(3):336–342.
26.
DahlAKLöppönenMIsoahoR. Overweight and obesity in old age are not associated with greater dementia risk. J Am Geriatr Soc. 2008;56(12):2261–2266.
27.
KukJLJaniszewskiPMRossR. Body mass index and hip and thigh circumferences are negatively associated with visceral adipose tissue after control for waist circumference. Am J Clin Nutr. 2007;85(6):1540–1544.
28.
NourhashémiFAndrieuSGillette-GuyonnetS. Is There a Relationship Between Fat-Free Soft Tissue Mass and Low Cognitive Function? Results From a Study of 7,105 Women. J Am Geriatr Soc. 2002;50(11):1796–1801.
29.
BurnsJMJohnsonDKWattsASwerdlowRHBrooksWM. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol. 2010;67(4):428–433.
30.
WhitmerRGustafsonDBarrett-ConnorEHaanMNGundersonEPYaffeK. Central obesity and increased risk of dementia more than three decades later. Neurology. 2008;71(14):1057–1064.
31.
WaldsteinSKatzelL. Interactive relations of central versus total obesity and blood pressure to cognitive function. Int J Obes. 2006;30(1):201–207.
32.
BuffaRMereuEPutzuPMereuRMMariniE. Lower lean mass and higher percent fat mass in patients with Alzheimer’s disease. Exp Gerontol. 2014;58:30–33.
33.
Iannuzzi-SucichMPrestwoodKMKennyAM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57(12):M772–M777.
34.
BaumgartnerRNWatersDLGallagherDMorleyJEGarryPJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev. 1999;107(2):123–136.
35.
JanickiSCSchupfN. Hormonal influences on cognition and risk for Alzheimer’s disease. Curr Neurol Neurosci Rep. 2010;10(5):359–366.
36.
TiidusPM.Benefits of Estrogen Replacement for Skeletal Muscle Mass and Function in Post-Menopausal Females: Evidence from Human and Animal Studies/Menopoz Sonrasi Kadinlarda Iskelet Kasi Kitle ve Fonksiyonu için Östrojen Replasmaninin Faydalari: Insan ve Hayvan Arastirmalari Bulgulari. Eurasian J Med. 2011;43(2):109.
37.
EvansWJLexellJ. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci. 1995;(50 Spec No):11–16.
38.
BaumgartnerRN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904(1):437–448.
39.
NewmanABKupelianVVisserM. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 2006;61(1):72–77.
40.
PowerBDAlfonsoHFlickerL. Body adiposity in later life and the incidence of dementia: the health in men study. PLoS One. 2011;6(3):e17902.
41.
ThomasDR. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr. 2007;26(4):389–399.
42.
BaggerYZTankóLBAlexandersenPQinGChristiansenC. The implications of body fat mass and fat distribution for cognitive function in elderly women. Obes Res. 2004;12(9):1519–1526.
43.
DoreGAEliasMFRobbinsMABudgeMMEliasPK. Relation between central adiposity and cognitive function in the Maine–Syracuse Study: attenuation by physical activity. Ann Behav Med. 2008;35(3):341–350.
44.
IkedaMBrownJHollandA. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2002;73(4):371–376.
45.
LaCroixAZGuralnikJMBerkmanLFWallaceRBSatterfieldS. Maintaining mobility in late life. II. Smoking, alcohol consumption, physical activity, and body mass index. Am J Epidemiol. 1993;137(8):858–869.
46.
JohannsenDLRavussinE. Obesity in the elderly: is faulty metabolism to blame?Aging Health. 2010;6(2):159–167.
47.
ClarkBCManiniTM. Functional consequences of sarcopenia and dynapenia in the elderly. Curr Opin Clin Nutr Metab Care. 2010;13(3):271–276.
48.
EliasMFGoodellALWaldsteinSR. Obesity, cognitive functioning and dementia: back to the future. J Alzheimers Dis. 2012;30(suppl 2):S113–S125.
49.
SrikanthanPKarlamanglaAS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011;96(9):2898–2903.
50.
CraftS. Insulin resistance and Alzheimer’s disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res. 2007;4(2):147–152.
51.
PouliotMCDesprésJPLemieuxS. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73(7):460–468.
52.
YaffeKKanayaALindquistK. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004;292(18):2237–2242.
53.
SchaapLAPluijmSMDeegDJVisserM. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119(6):526. e9–e17.
54.
FontanaLEagonJCTrujilloMESchererPEKleinS. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56(4):1010–1013.
HausdorffJMBuchmanAS. What links gait speed and MCI with dementia? A fresh look at the association between motor and cognitive function. J Gerontol A Biol Sci Med Sci. 2013:68(4):409–411.
57.
LandiFAbbatecolaAMProvincialiM. Moving against frailty: does physical activity matter?Biogerontology. 2010;11(5):537–545.
58.
Abellan van KanGCesariMGillette-GuyonnetS. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing. 2013;42(2):196–202.
59.
NganduTLehtisaloJSolomonA. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–2263.
60.
OzawaMShipleyMKivimakiM. Dietary Pattern, Inflammation and Cognitive Decline: the Whitehall II Prospective Cohort Study [published online January 29, 2016]. Clin Nutr. 2016.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
